Substantial shareholder list, page-3

@Col, I'll keep it short because there are too many rampers that will just add rubbish to this thread.

Patient numbers required are more than double in the Phase 2 as the Phase 1 for Dep Docetaxel.
Its logical that Starpharma would need to recruit twice as fast to complete the trial in the same period of time.

If they dont provide the number of patients recruited in the updates it would be a little foolish in my opinion to just assume they are recruiting more than twice as fast than the Phase 1 trial.

Good luck